In particular, antibodies directed against thrombin, PC, plasmin, and FXa have been evident in SLE and APS [15,31,32,33], which potentiate rather than inhibit thrombotic and procoagulant effects [15,16,34]. The gene discussed is PLG; the disease is systemic lupus erythematosus.